BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans. 1976

P H Hinderling, and E R Garrett

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004206 Disopyramide A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties. Diisopyramide,Disopyramide Monohydrochloride,Disopyramide Phosphate,Disopyramide Phosphate (1:1),Disopyramide Phosphate (1:1), (+-)-Isomer,Disopyramide Phosphate (1:1), (R)-Isomer,Disopyramide Phosphate (1:1), (S)-Isomer,Disopyramide, (+-)-Isomer,Disopyramide, (R)-Isomer,Disopyramide, (S)-Isomer,Disopyramide, D-Tartrate (1:1), (S)-Isomer,Disopyramide, L-Tartrate (1:1), (R)-Isomer,Disopyramide, L-Tartrate (1:1), (S)-Isomer,Disopyramide, L-Tartrate (1:2), (+-)-Isomer,Disopyramide, L-Tartrate, (S)-isomer,Norpace,Palpitin,Palpitine,Rhythmodan,Ritmilen,Rythmilen,SC-13957,SC 13957,SC13957
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P H Hinderling, and E R Garrett
The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
May 1982, International journal of clinical pharmacology, therapy, and toxicology,
P H Hinderling, and E R Garrett
Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
P H Hinderling, and E R Garrett
Comparative pharmacokinetics of unbound disopyramide enantiomers following oral administration of racemic disopyramide in humans.
July 1991, Journal of pharmaceutical sciences,
P H Hinderling, and E R Garrett
Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
January 2001, International journal of clinical pharmacology research,
P H Hinderling, and E R Garrett
The pharmacokinetics of furazlocillin in healthy humans.
February 1983, Journal of pharmacokinetics and biopharmaceutics,
P H Hinderling, and E R Garrett
Disopyramide--a new antiarrhythmic agent.
April 1978, Connecticut medicine,
P H Hinderling, and E R Garrett
[Disopyramide: a new antiarrhythmic drug].
November 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P H Hinderling, and E R Garrett
[A new antiarrhythmic agent: disopyramide].
September 1968, La Presse medicale,
P H Hinderling, and E R Garrett
[The antiarrhythmic effect of intravenously administered disopyramide].
June 1982, Vnitrni lekarstvi,
P H Hinderling, and E R Garrett
[Pharmacokinetics of propranolol in healthy humans].
November 1981, Die Pharmazie,
Copied contents to your clipboard!